Douglas G. Cole

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Douglas G. Cole
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas G. Cole:

Company Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 26,564 $489,309 $18.42 01 Jun 2023 Direct
Foghorn Therapeutics Inc. Director Stock Option (right to buy) 25,000 $119,750 $4.79 17 Jun 2025 Direct
Sana Biotechnology, Inc. Director Stock Option (Right to Buy) 65,000 06 Jun 2024 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 12,649 01 Jun 2023 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.7500 11 Aug 2023 Direct

Insider Reports Filed by Douglas G. Cole

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 17 Jun 2025 1 +$119,750 4 Director 17 Jun 2025, 16:25
FHTX Foghorn Therapeutics Inc. 26 Jun 2024 1 +$88,320 4 Director 28 Jun 2024, 16:03
SANA Sana Biotechnology, Inc. 06 Jun 2024 1 $0 4/A Director 15 Jul 2024, 16:11
SANA Sana Biotechnology, Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:21
/report/000141588923012136-cole-douglas-g-2023-08-11 Sigilon Therapeutics, Inc. 11 Aug 2023 2 -$7,952 4 Director 11 Aug 2023, 16:10
FHTX Foghorn Therapeutics Inc. 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:14
SANA Sana Biotechnology, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:33
DNLI Denali Therapeutics Inc. 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 18:01
/report/000141588923008492-cole-douglas-g-2023-05-19 Sigilon Therapeutics, Inc. 19 May 2023 1 $0 4 Director 22 May 2023, 16:20
FHTX Foghorn Therapeutics Inc. 21 Jun 2022 1 $0 4 Director 22 Jun 2022, 21:00
SANA Sana Biotechnology, Inc. 06 Jun 2022 1 $0 4 Director 08 Jun 2022, 18:35
DNLI Denali Therapeutics Inc. 02 Jun 2022 2 $0 4 Director 06 Jun 2022, 20:09
/report/000141588922005826-cole-douglas-g-2022-05-26 Sigilon Therapeutics, Inc. 26 May 2022 1 $0 4 Director 27 May 2022, 17:00
FHTX Foghorn Therapeutics Inc. 13 Jul 2021 1 $0 4 Director 14 Jul 2021, 16:52
/report/000141588921003236-cole-douglas-g-2021-06-24 Sigilon Therapeutics, Inc. 24 Jun 2021 1 +$88,613 4 Director 28 Jun 2021, 07:15
DNLI Denali Therapeutics Inc. 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 18:31
DNLI Denali Therapeutics Inc. 01 Jun 2021 2 $0 4 Director 03 Jun 2021, 20:51